S3840
HCPCSDna analysis ret-oncogene
Official HCPCS Level II long descriptor
Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2
HCPCS Level II code S3840 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Dna analysis ret-oncogene
Added to HCPCS: 2003-07-01
Nearby codes in S3
- S3630Eosinophil blood count
- S3645Hiv-1 antibody testing of or
- S3650Saliva test, hormone level;
- S3652Saliva test, hormone level;
- S3655Antisperm antibodies test
- S3708Gastrointestinal fat absorpt
- S3722Dose optimization auc - 5fu
- S3800Genetic testing als
- S3841Gene test retinoblastoma
- S3842Gene test hippel-lindau
- S3844Dna analysis deafness
- S3845Gene test alpha-thalassemia
- S3846Gene test beta-thalassemia
- S3849Gene test niemann-pick
- S3850Gene test sickle cell
- S3852Dna analysis apoe alzheimer
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.